Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson, Ulrich Knigge, Gitte Dam, Birgitte Federspiel, Henning Grønbaek, Peter Stålberg, Seppo W Langer, Andreas Kjaer, Johanna Arola, Camilla Schalin-Jäntti, Anders Sundin, Staffan Welin, Espen Thiis-Evensen, Halfdan Sorbye

34 Citationer (Scopus)

Abstract

BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind60
Udgave nummer7
Sider (fra-til)931-941
Antal sider11
ISSN0284-186X
DOI
StatusUdgivet - jul. 2021

Fingeraftryk

Dyk ned i forskningsemnerne om 'Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms'. Sammen danner de et unikt fingeraftryk.

Citationsformater